RenovoRx Inc (RNXT)

Over the past 90 days, RenovoRx Inc. recorded one insider transaction, a purchase of $19,690 by Chief Financial Officer Mark Voll on May 19, 2026. This follows a period of consistent buying activity by executives. The stock has seen a 1.8% decline over the last quarter, with the next earnings report scheduled for August 2026.
Ticker: RNXT Exchange: NAS


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for RenovoRx Inc. Upgrade to see score, net flow, insiders and the full signal context.

Top insiders
Trades
Buy 19 May 2026
Value US$1,203,205.87 | Price 430.31 | Shares 78,486 (+29.8%)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value
Number of shares Price Value Details
2026-05-21 2026-05-19 B Purchase

Chief Financial Officer

Officer
78,486 +29.8%
430.31
US$1,203,206
78,486 +29.8% 430.31 US$1,203,206
2026-01-22 2026-01-21 B Purchase

Chief Medical Officer

Executive Director
84,108 -13.5%
345.07
US$3,775,224
84,108 -13.5% 345.07 US$3,775,224
2026-01-05 2025-12-31 B Purchase

Chief Medical Officer

Executive Director
92,481 -20.7%
171.62
US$3,177,526
92,481 -20.7% 171.62 US$3,177,526
2026-01-02 2025-12-30 B Purchase

Chief Medical Officer

Executive Director
205 +0.0%
0.83
US$169
205 +0.0% 0.83 US$169
2025-12-22 2025-12-18 B Purchase

Chief Executive Officer

Executive Director
5,000 +1.5%
0.90
US$4,506
5,000 +1.5% 0.90 US$4,506
2025-12-19 2025-12-17 B Purchase

Chief Executive Officer

Executive Director
5,000 +1.5%
0.85
US$4,262
5,000 +1.5% 0.85 US$4,262
2025-12-17 2025-12-16 B Purchase

Chief Medical Officer

Executive Director
12,000 +1.6%
0.85
US$10,200
12,000 +1.6% 0.85 US$10,200
2025-12-08 2025-12-05 B Purchase

Chief Medical Officer

Executive Director
10,000 +1.3%
0.96
US$9,600
10,000 +1.3% 0.96 US$9,600
2025-11-24 2025-11-24 B Purchase

Chief Medical Officer

Executive Director
12,000 +1.6%
0.80
US$9,600
12,000 +1.6% 0.80 US$9,600
2025-11-24 2025-11-21 B Purchase

Chief Medical Officer

Executive Director
10,000 +1.4%
0.80
US$8,000
10,000 +1.4% 0.80 US$8,000
2025-08-26 2025-08-25 B Purchase

Chief Executive Officer

Executive Director
5,000 +1.5%
0.91
US$4,549
5,000 +1.5% 0.91 US$4,549
2025-08-26 2025-08-22 B Purchase

Chief Executive Officer

Executive Director
5,000 +1.6%
0.95
US$4,748
5,000 +1.6% 0.95 US$4,748
2025-06-09 2025-06-05 B Purchase

Chief Medical Officer

Executive Director
21,000 +2.9%
1.40
US$29,400
21,000 +2.9% 1.40 US$29,400
2025-04-17 2025-04-15 B Purchase

Chief Medical Officer

Executive Director
15,000 +1.4%
0.90
US$13,500
15,000 +1.4% 0.90 US$13,500
2025-04-16 2025-04-15 B Purchase

Chief Executive Officer

Executive Director
7,500 +2.4%
0.91
US$6,821
7,500 +2.4% 0.91 US$6,821
2025-04-14 2025-04-11 B Purchase

Chief Medical Officer

Executive Director
20,000 +1.9%
0.80
US$16,000
20,000 +1.9% 0.80 US$16,000
2025-04-10 2025-04-10 B Purchase

VP Controller and PAO

Officer
6,500 +106.6%
0.79
US$5,135
6,500 +106.6% 0.79 US$5,135
2025-04-10 2025-04-09 B Purchase

VP Controller and PAO

Officer
6,000 +6315.8%
0.80
US$4,800
6,000 +6315.8% 0.80 US$4,800
2025-04-10 2025-04-09 B Purchase

Chief Medical Officer

Executive Director
30,000 +2.9%
0.81
US$24,399
30,000 +2.9% 0.81 US$24,399
2025-04-10 2025-04-09 B Purchase

Chief Executive Officer

Executive Director
10,000 +3.3%
0.83
US$8,300
10,000 +3.3% 0.83 US$8,300
2025-04-10 2025-04-08 B Purchase

VP Controller and PAO

Officer
95 +inf%
0.80
US$76
95 +inf% 0.80 US$76
2025-04-09 2025-04-08 B Purchase Non-Executive Director
12,050 +35.8%
0.85
US$10,218
12,050 +35.8% 0.85 US$10,218
2025-04-09 2025-04-08 B Purchase

Chief Medical Officer

Executive Director
26,000 +2.5%
0.84
US$21,840
26,000 +2.5% 0.84 US$21,840
2025-04-08 2025-04-07 B Purchase

Chief Executive Officer

Executive Director
10,000 +3.4%
0.83
US$8,300
10,000 +3.4% 0.83 US$8,300
2024-01-30 2024-01-26 B Purchase

Chief Executive Officer

Executive Director
40,983
0.00
US$0
40,983 0.00 US$0
2024-01-30 2024-01-26 B Purchase Non-Executive Director
40,983
0.00
US$0
40,983 0.00 US$0
2024-01-30 2024-01-26 B Purchase Non-Executive Director
40,983
0.00
US$0
40,983 0.00 US$0
2024-01-30 2024-01-26 B Purchase

Chief Medical Officer

Executive Director
40,983
0.00
US$0
40,983 0.00 US$0
2024-01-30 2024-01-26 B Purchase Non-Executive Director
8,196
0.00
US$0
8,196 0.00 US$0
2023-10-04 2023-10-03 B Purchase

Chief Operating Officer

Officer
800 +266.7%
1.05
US$836
800 +266.7% 1.05 US$836
2023-10-04 2023-10-03 B Purchase

Chief Operating Officer

Officer
300 +inf%
1.05
US$315
300 +inf% 1.05 US$315
2022-06-09 2022-06-07 B Purchase

Chief Medical Officer

Executive Director Large shareholder
5,182 +400.2%
1.93
US$10,001
5,182 +400.2% 1.93 US$10,001
2022-05-23 2022-05-19 B Purchase

Chief Executive Officer

Executive Director
5,500 +2.2%
2.05
US$11,275
5,500 +2.2% 2.05 US$11,275